Keyphrases
Cell Morphology
100%
Large Cell
100%
NKT Cells
100%
Nasal
100%
Advanced Disease
100%
TP53 mutation
100%
Mexico
100%
Cell Lymphoma
100%
Overexpression
80%
P53 Gene
80%
NK-T Cell Lymphoma
80%
Tumor Cells
40%
Ultra-high Performance Liquid Chromatography (UHPLC)
40%
Overexpressing
40%
Polymerase Chain Reaction
40%
I to
40%
Transformed Cells
40%
P53 Protein
40%
Loss of Heterozygosity
40%
P53 Expression
40%
P53 Wild Type
40%
No Evidence of Disease
40%
Medium Size
20%
Missense mutation
20%
Epstein-Barr Virus
20%
Reaction Products
20%
Disease Stage
20%
Lymphoma
20%
Epstein-Barr Virus Infections
20%
Advanced Stage Disease
20%
Downstream Targets
20%
Exon 5
20%
F-ratio
20%
Mixed Cell
20%
Stage IVB
20%
Cyclin-dependent Kinase Inhibitor p21
20%
Geographic Distribution
20%
Medicine and Dentistry
Lymphoma Cell
100%
Protein P53
100%
Large Cell
100%
Diseases
100%
P21
20%
NK T Cell Lymphoma
16%
Clinical Stage
12%
Morphology
8%
Tumor Cell
8%
High-Performance Liquid Chromatography
8%
Heterozygosity
8%
Transformed Cell
8%
Polymerase Chain Reaction
8%
Allele
4%
Missense Mutation
4%
Epstein Barr Virus
4%
Epstein-Barr Virus Infection
4%
Cyclin Dependent Kinase Inhibitor 1A
4%
Geographic Distribution
4%
Chromosome 17p
4%
Exon
4%
Immunology and Microbiology
Lymphoma Cell
100%
P53
100%
Natural Killer T Cell
20%
Protein P53
20%
Liquid Chromatography
10%
Tumor Cell
10%
Morphology
10%
Heterozygosity
10%
Transformed Cell
10%
Wild Type
10%
Polymerase Chain Reaction
10%
Epstein Barr Virus
10%
Viral Disease
5%
Cycline
5%
Missense Mutation
5%
Geographic Distribution
5%
Chromosome 17p
5%
Exon
5%
Allele
5%
Biochemistry, Genetics and Molecular Biology
P53
100%
P21
30%
Protein P53
20%
Natural Killer T Cell
20%
Wild Type
10%
Loss of Heterozygosity
10%
Morphology
10%
Epstein Barr Virus
10%
High-Performance Liquid Chromatography
10%
Polymerase Chain Reaction
10%
Exon
5%
Allele
5%
Missense Mutation
5%
Geographic Distribution
5%
Chromosome 17p
5%
Cyclin-Dependent Kinase
5%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Diseases
100%
NK T Cell Lymphoma
16%
Hyperbarism
8%
Neoplasm
8%
Epstein-Barr Virus
4%
Epstein Barr Virus Infection
4%
Cyclin Dependent Kinase Inhibitor 1A
4%
Geographic Distribution
4%
Veterinary Science and Veterinary Medicine
P53
100%
T-Cell Lymphoma
16%
Natural Killer T Cell
16%
Epstein-Barr Virus
8%
Neoplasm
8%
Polymerase Chain Reaction
8%
Virus Infection
4%